{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:16:26Z","timestamp":1793643386691,"version":"4.5.1"},"reference-count":103,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":1121,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Until recently, in vivo and ex vivo experiments were the only means to determine factors and pathways involved in disease pathophysiology. After the generation of characterized human embryonic stem cell lines, human diseases could readily be studied in an extensively controllable setting. The introduction of human-induced pluripotent stem cells, a decade ago, allowed the investigation of hereditary diseases in vitro. In the field of cardiology, diseases linked to known genes have successfully been studied, revealing novel disease mechanisms. The direct effects of various mutations leading to hypertrophic cardiomyopathy, dilated cardiomyopathy, arrythmogenic cardiomyopathy, or left ventricular noncompaction cardiomyopathy are discovered as a result of in vitro disease modeling. Researchers are currently applying more advanced techniques to unravel more complex phenotypes, resulting in state-of-the-art models that better mimic in vivo physiology. The continued improvement of tissue engineering techniques and new insights into epigenetics resulted in more reliable and feasible platforms for disease modeling and the development of novel therapeutic strategies. The introduction of CRISPR-Cas9 gene editing granted the ability to model diseases in vitro independent of induced pluripotent stem cells. In addition to highlighting recent developments in the field of human in vitro cardiomyopathy modeling, this review also aims to emphasize limitations that remain to be addressed; including residual somatic epigenetic signatures induced pluripotent stem cells, and modeling diseases with unknown genetic causes. Stem Cells Translational Medicine \u00a02019;8:66\u201374<\/jats:p>","DOI":"10.1002\/sctm.18-0052","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T06:41:09Z","timestamp":1539153669000},"page":"66-74","source":"Crossref","is-referenced-by-count":37,"title":["Concise Review: The Current State of Human In Vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue Engineering"],"prefix":"10.1093","volume":"8","author":[{"given":"Martijn F.","family":"Hoes","sequence":"first","affiliation":[{"name":"Department of Cardiology University Medical Center Groningen, University of Groningen, Groningen, RB, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Bomer","sequence":"additional","affiliation":[{"name":"Department of Cardiology University Medical Center Groningen, University of Groningen, Groningen, RB, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Meer","sequence":"additional","affiliation":[{"name":"Department of Cardiology University Medical Center Groningen, University of Groningen, Groningen, RB, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,9]]},"reference":[{"key":"2022022810152016000_sct312394-bib-0001","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics\u20142018 update: A report from the American heart association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"2022022810152016000_sct312394-bib-0002","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy","volume":"381","author":"Maron","year":"2013","journal-title":"Lancet"},{"key":"2022022810152016000_sct312394-bib-0003","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet"},{"key":"2022022810152016000_sct312394-bib-0004","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/hmg\/3.6.959","article-title":"The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23\u2013q24","volume":"3","author":"Rampazzo","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2022022810152016000_sct312394-bib-0005","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(09)62023-7","article-title":"Dilated cardiomyopathy","volume":"375","author":"Jefferies","year":"2010","journal-title":"Lancet"},{"key":"2022022810152016000_sct312394-bib-0006","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1126\/science.282.5391.1061","article-title":"New potential for human embryonic stem cells","volume":"282","author":"Gearhart","year":"1998","journal-title":"Science"},{"key":"2022022810152016000_sct312394-bib-0007","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"2022022810152016000_sct312394-bib-0008","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yjmcc.2005.03.003","article-title":"Novel cell lines derived from adult human ventricular cardiomyocytes","volume":"39","author":"Davidson","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"2022022810152016000_sct312394-bib-0009","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1016\/j.bpj.2009.02.019","article-title":"Novel micropatterned cardiac cell cultures with realistic ventricular microstructure","volume":"96","author":"Badie","year":"2009","journal-title":"Biophys J"},{"key":"2022022810152016000_sct312394-bib-0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/CIRCRESAHA.108.182469","article-title":"Myofibrillar architecture in engineered cardiac myocytes","volume":"103","author":"Parker","year":"2008","journal-title":"Circ Res"},{"key":"2022022810152016000_sct312394-bib-0011","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1039\/b704961g","article-title":"An on-chip cardiomyocyte cell network assay for stable drug screening regarding community effect of cell network size","volume":"132","author":"Kaneko","year":"2007","journal-title":"Analyst"},{"key":"2022022810152016000_sct312394-bib-0012","first-page":"1008","article-title":"Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells","volume":"144","author":"Giacomelli","year":"2017","journal-title":"Development"},{"key":"2022022810152016000_sct312394-bib-0013","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.ymthe.2018.02.012","article-title":"Human ISL1 + ventricular progenitors self-assemble into an in vivo functional heart patch and preserve cardiac function post infarction","volume":"26","author":"Foo","year":"2018","journal-title":"Mol Ther"},{"key":"2022022810152016000_sct312394-bib-0014","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00018-009-8476-0","article-title":"Human stem cells as a model for cardiac differentiation and disease","volume":"66","author":"Beqqali","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"2022022810152016000_sct312394-bib-0015","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1582-4934.2012.01528.x","article-title":"Cardiac differentiation of human pluripotent stem cells","volume":"16","author":"Jiang","year":"2012","journal-title":"J Cell Mol Med"},{"key":"2022022810152016000_sct312394-bib-0016","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI200112131","article-title":"Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes","volume":"108","author":"Kehat","year":"2001","journal-title":"J Clin Invest"},{"key":"2022022810152016000_sct312394-bib-0017","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/CIRCRESAHA.117.311080","article-title":"Induced pluripotent stem cells 10 years later","volume":"120","author":"Yoshida","year":"2017","journal-title":"Circ Res"},{"key":"2022022810152016000_sct312394-bib-0018","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.stem.2016.07.006","article-title":"Transcriptome profiling of patient-specific human iPSC-cardiomyocytes predicts individual drug safety and efficacy responses in vitro","volume":"19","author":"Matsa","year":"2016","journal-title":"Cell Stem Cell"},{"key":"2022022810152016000_sct312394-bib-0019","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.yjmcc.2014.04.005","article-title":"Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells","volume":"72","author":"Yang","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"2022022810152016000_sct312394-bib-0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.biomaterials.2015.01.067","article-title":"Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro\u2013correlation between contraction force and electrophysiology","volume":"51","author":"Ribeiro","year":"2015","journal-title":"Biomaterials"},{"key":"2022022810152016000_sct312394-bib-0021","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.114.014998","article-title":"Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue","volume":"134","author":"Ruan","year":"2016","journal-title":"Circulation"},{"key":"2022022810152016000_sct312394-bib-0022","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41586-018-0016-3","article-title":"Advanced maturation of human cardiac tissue grown from pluripotent stem cells","volume":"556","author":"Ronaldson-Bouchard","year":"2018","journal-title":"Nature"},{"key":"2022022810152016000_sct312394-bib-0023","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/CIRCRESAHA.115.306874","article-title":"Bioengineering human myocardium on native extracellular matrix","volume":"118","author":"Guyette","year":"2016","journal-title":"Circ Res"},{"key":"2022022810152016000_sct312394-bib-0024","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.RES.0000257776.05673.ff","article-title":"Tissue engineering of vascularized cardiac muscle from human embryonic stem cells","volume":"100","author":"Caspi","year":"2007","journal-title":"Circ Res"},{"key":"2022022810152016000_sct312394-bib-0025","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/s41467-017-01946-x","article-title":"Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues","volume":"8","author":"Shadrin","year":"2017","journal-title":"Nat Commun"},{"key":"2022022810152016000_sct312394-bib-0026","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41569-018-0032-x","article-title":"Exercising engineered heart muscle to maturity","volume":"15","author":"Zhang","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2022022810152016000_sct312394-bib-0027","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature13596","article-title":"A long noncoding RNA protects the heart from pathological hypertrophy","volume":"514","author":"Han","year":"2014","journal-title":"Nature"},{"key":"2022022810152016000_sct312394-bib-0028","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/CIRCRESAHA.108.183426","article-title":"Toward microRNA-based therapeutics for heart disease: The sense in antisense","volume":"103","author":"Van Rooij","year":"2008","journal-title":"Circ Res"},{"key":"2022022810152016000_sct312394-bib-0029","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cell.2013.07.013","article-title":"BET bromodomains mediate transcriptional pause release in heart failure","volume":"154","author":"Anand","year":"2013","journal-title":"Cell"},{"key":"2022022810152016000_sct312394-bib-0030","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","article-title":"The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms","volume":"104","author":"Seidman","year":"2001","journal-title":"Cell"},{"key":"2022022810152016000_sct312394-bib-0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ddtec.2018.06.002","article-title":"CRISPR\/Cas9-mediated genome editing in human stem cell-derived cardiomyocytes: Applications for cardiovascular disease modelling and cardiotoxicity screening","author":"Christidi","year":"2018","journal-title":"Drug Discov Today Technol"},{"key":"2022022810152016000_sct312394-bib-0032","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu205","article-title":"Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells","volume":"104","author":"Han","year":"2014","journal-title":"Cardiovasc Res"},{"key":"2022022810152016000_sct312394-bib-0033","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2022022810152016000_sct312394-bib-0034","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.omtn.2017.05.008","article-title":"Evaluation of MYBPC3 trans -splicing and gene replacement as therapeutic options in human iPSC-Derived cardiomyocytes","volume":"7","author":"Prondzynski","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"2022022810152016000_sct312394-bib-0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/1684792","article-title":"Mutation-specific phenotypes in hiPSC-derived cardiomyocytes carrying either myosin-binding protein C Or \u03b1 -tropomyosin mutation for hypertrophic cardiomyopathy","volume":"2016","author":"Ojala","year":"2016","journal-title":"Stem Cells Int"},{"key":"2022022810152016000_sct312394-bib-0036","doi-asserted-by":"crossref","first-page":"e001263","DOI":"10.1161\/JAHA.114.001263","article-title":"Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes","volume":"3","author":"Tanaka","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2022022810152016000_sct312394-bib-0037","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.celrep.2015.09.025","article-title":"Contractile defect caused by mutation in MYBPC3 revealed under conditions optimized for human PSC-cardiomyocyte function","volume":"13","author":"Birket","year":"2015","journal-title":"Cell Rep"},{"key":"2022022810152016000_sct312394-bib-0038","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1126\/science.aaa5458","article-title":"Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy","volume":"349","author":"Hinson","year":"2015","journal-title":"Science"},{"key":"2022022810152016000_sct312394-bib-0039","doi-asserted-by":"crossref","first-page":"e005677","DOI":"10.1161\/JAHA.117.005677","article-title":"Modeling treatment response for lamin A\/C related dilated cardiomyopathy in human induced pluripotent stem cells","volume":"6","author":"Lee","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2022022810152016000_sct312394-bib-0040","doi-asserted-by":"crossref","first-page":"130ra47","DOI":"10.1126\/scitranslmed.3003552","article-title":"Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy","volume":"4","author":"Sun","year":"2012","journal-title":"Sci Transl Med"},{"key":"2022022810152016000_sct312394-bib-0041","doi-asserted-by":"crossref","first-page":"H107","DOI":"10.1152\/ajpheart.00162.2016","article-title":"A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation","volume":"311","author":"Broughton","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022022810152016000_sct312394-bib-0042","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/hmg\/dds556","article-title":"Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing","volume":"22","author":"Tse","year":"2013","journal-title":"Hum Mol Genet"},{"key":"2022022810152016000_sct312394-bib-0043","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/hmg\/ddv468","article-title":"Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells","volume":"25","author":"Wyles","year":"2016","journal-title":"Hum Mol Genet"},{"key":"2022022810152016000_sct312394-bib-0044","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yjmcc.2017.09.008","article-title":"Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes","volume":"113","author":"Streckfuss-B\u00f6meke","year":"2017","journal-title":"J Mol Cell Cardiol"},{"key":"2022022810152016000_sct312394-bib-0045","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1093\/eurheartj\/ehw307","article-title":"Genomic correction of familial cardiomyopathy in human engineered cardiac tissues","volume":"37","author":"Stillitano","year":"2016","journal-title":"Eur Heart J"},{"key":"2022022810152016000_sct312394-bib-0046","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1038\/ncomms7955","article-title":"Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy","volume":"6","author":"Karakikes","year":"2015","journal-title":"Nat Commun"},{"key":"2022022810152016000_sct312394-bib-0047","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature11799","article-title":"Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs","volume":"494","author":"Kim","year":"2013","journal-title":"Nature"},{"key":"2022022810152016000_sct312394-bib-0048","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/eurheartj\/ehs226","article-title":"Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy","volume":"34","author":"Ma","year":"2013","journal-title":"Eur Heart J"},{"key":"2022022810152016000_sct312394-bib-0049","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/CIRCGENETICS.113.000188","article-title":"Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells","volume":"6","author":"Caspi","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"2022022810152016000_sct312394-bib-0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/cvr\/cvw234","article-title":"Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia\/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis","volume":"113","author":"Te Riele","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2022022810152016000_sct312394-bib-0051","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ncb3411","article-title":"iPSC-derived cardiomyocytes reveal abnormal TGF-\u03b2 signalling in left ventricular non-compaction cardiomyopathy","volume":"18","author":"Kodo","year":"2016","journal-title":"Nat Cell Biol"},{"key":"2022022810152016000_sct312394-bib-0052","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm.4087","article-title":"Human induced pluripotent stem cell\u2013derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity","volume":"22","author":"Burridge","year":"2016","journal-title":"Nat Med"},{"key":"2022022810152016000_sct312394-bib-0053","doi-asserted-by":"crossref","first-page":"eaaf2584","DOI":"10.1126\/scitranslmed.aaf2584","article-title":"High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells","volume":"9","author":"Sharma","year":"2017","journal-title":"Sci Transl Med"},{"key":"2022022810152016000_sct312394-bib-0054","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5966\/sctm.2013-0105","article-title":"An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes","volume":"3","author":"Jiang","year":"2014","journal-title":"Stem Cells Transl Med"},{"key":"2022022810152016000_sct312394-bib-0055","doi-asserted-by":"crossref","first-page":"e102796","DOI":"10.1371\/journal.pone.0102796","article-title":"Directed differentiation of patient-specific induced pluripotent stem cells identifies the transcriptional repression and epigenetic modification of NKX2-5, HAND1, and NOTCH1 in hypoplastic left heart syndrome","volume":"9","author":"Kobayashi","year":"2014","journal-title":"PLoS One"},{"key":"2022022810152016000_sct312394-bib-0056","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10821","article-title":"Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells","volume":"482","author":"Israel","year":"2012","journal-title":"Nature"},{"key":"2022022810152016000_sct312394-bib-0057","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.scr.2017.06.006","article-title":"Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy","volume":"22","author":"Wing","year":"2017","journal-title":"Stem Cell Res"},{"key":"2022022810152016000_sct312394-bib-0058","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nm.4238","article-title":"Patient-derived induced pluripotent stem cells in cancer research and precision oncology","volume":"22","author":"Papapetrou","year":"2016","journal-title":"Nat Med"},{"key":"2022022810152016000_sct312394-bib-0059","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.stem.2016.04.013","article-title":"Induced pluripotent stem cells meet genome editing","volume":"18","author":"Hockemeyer","year":"2016","journal-title":"Cell Stem Cell"},{"key":"2022022810152016000_sct312394-bib-0060","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat Protoc"},{"key":"2022022810152016000_sct312394-bib-0061","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"2022022810152016000_sct312394-bib-0062","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/CIRCRESAHA.116.309948","article-title":"A comprehensive TALEN-based knockout library for generating human-induced pluripotent stem cell-based models for cardiovascular diseases","volume":"120","author":"Karakikes","year":"2017","journal-title":"Circ Res"},{"key":"2022022810152016000_sct312394-bib-0063","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/ejhf.826","article-title":"Effect of intracoronary administration of AAV1\/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial on behalf of the AGENT-HF Investigators","volume":"19","author":"Hulot","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2022022810152016000_sct312394-bib-0064","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): A phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"key":"2022022810152016000_sct312394-bib-0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23305","article-title":"Correction of a pathogenic gene mutation in human embryos","volume":"548","author":"Ma","year":"2017","journal-title":"Nature"},{"key":"2022022810152016000_sct312394-bib-0066","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/cvr\/cvw234","article-title":"Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia\/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis","volume":"113","author":"Riele","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2022022810152016000_sct312394-bib-0067","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yjmcc.2018.02.007","article-title":"Establishment of a PRKAG2 cardiac syndrome disease model and mechanism study using human induced pluripotent stem cells","volume":"117","author":"Zhan","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"2022022810152016000_sct312394-bib-0068","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.hrthm.2017.09.024","article-title":"CRISPR correction of the PRKAG2 gene mutation in the patient\u2019s induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities","volume":"15","author":"Ben Jehuda","year":"2018","journal-title":"Heart Rhythm"},{"key":"2022022810152016000_sct312394-bib-0069","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95918","article-title":"Functional correction of dystrophin actin binding domain mutations by genome editing","volume":"2","author":"Kyrychenko","year":"2017","journal-title":"JCI Insight"},{"key":"2022022810152016000_sct312394-bib-0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCRESAHA.116.309283","article-title":"A precision medicine approach to the rescue of function on malignant calmodulinopathic long-QT syndromenovelty and significance","volume":"120","author":"Limpitikul","year":"2017","journal-title":"Circ Res"},{"key":"2022022810152016000_sct312394-bib-0071","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/hmg\/ddx073","article-title":"Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation","volume":"26","author":"Yamamoto","year":"2017","journal-title":"Hum Mol Genet"},{"key":"2022022810152016000_sct312394-bib-0072","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/scd.2017.0268","article-title":"Simplified Footprint-Free Cas9\/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells","volume":"27","author":"Kondrashov","year":"2018","journal-title":"Stem Cells Dev"},{"key":"2022022810152016000_sct312394-bib-0073","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.yjmcc.2017.12.002","article-title":"Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes","volume":"114","author":"Wang","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"2022022810152016000_sct312394-bib-0074","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nmeth.3284","article-title":"Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells","volume":"12","author":"Kim","year":"2015","journal-title":"Nat Methods"},{"key":"2022022810152016000_sct312394-bib-0075","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat Biotechnol"},{"key":"2022022810152016000_sct312394-bib-0076","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR\u2013Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"2022022810152016000_sct312394-bib-0077","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.aaq0180","article-title":"RNA editing with CRISPR-Cas13","volume":"358","author":"Cox","year":"2017","journal-title":"Science"},{"key":"2022022810152016000_sct312394-bib-0078","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nature24049","article-title":"RNA targeting with CRISPR\u2013Cas13","volume":"550","author":"Abudayyeh","year":"2017","journal-title":"Nature"},{"key":"2022022810152016000_sct312394-bib-0079","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/eurheartj\/ehx341","article-title":"Vitamin D supplementation in heart failure: case closed?","volume":"38","author":"Boer","year":"2017","journal-title":"Eur Heart J"},{"key":"2022022810152016000_sct312394-bib-0080","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ejhf.1154","article-title":"Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function","volume":"20","author":"Hoes","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2022022810152016000_sct312394-bib-0081","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"key":"2022022810152016000_sct312394-bib-0082","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.stemcr.2018.01.016","article-title":"Modeling human cardiac hypertrophy in stem cell-derived cardiomyocytes","volume":"10","author":"Ovchinnikova","year":"2018","journal-title":"Stem Cell Rep"},{"key":"2022022810152016000_sct312394-bib-0083","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2015.152","article-title":"Environmental factors in cardiovascular disease","volume":"12","author":"Cosselman","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2022022810152016000_sct312394-bib-0084","doi-asserted-by":"crossref","first-page":"e000490","DOI":"10.1161\/JAHA.113.000490","article-title":"History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the coronary artery risk development in young adults study","volume":"3","author":"Gunderson","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2022022810152016000_sct312394-bib-0085","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/0002-9378(91)90012-G","article-title":"Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women","volume":"165","author":"Catalano","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"2022022810152016000_sct312394-bib-0086","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature09342","article-title":"Epigenetic memory in induced pluripotent stem cells","volume":"467","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"2022022810152016000_sct312394-bib-0087","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.mam.2012.08.002","article-title":"Cellular reprogramming to reset epigenetic signatures","volume":"34","author":"Hewitt","year":"2013","journal-title":"Mol Asp Med"},{"key":"2022022810152016000_sct312394-bib-0088","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jps.22257","article-title":"A review of three-dimensional in vitro tissue models for drug discovery and transport studies","volume":"100","author":"Elliott","year":"2011","journal-title":"J Pharm Sci"},{"key":"2022022810152016000_sct312394-bib-0089","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.stemcr.2015.10.017","article-title":"Integrated analysis of contractile kinetics, force generation, and electrical activity in single human stem cell-derived cardiomyocytes","volume":"5","author":"Kijlstra","year":"2015","journal-title":"Stem Cell Rep"},{"key":"2022022810152016000_sct312394-bib-0090","first-page":"H433","article-title":"Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies","volume":"277","author":"Bursac","year":"1999","journal-title":"Am J Phys"},{"key":"2022022810152016000_sct312394-bib-0091","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/scientificamerican0559-132","article-title":"Tissues from dissociated cells","volume":"200","author":"Moscona","year":"1959","journal-title":"Sci Am"},{"key":"2022022810152016000_sct312394-bib-0092","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1096\/fasebj.11.8.9240969","article-title":"Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system","volume":"11","author":"Eschenhagen","year":"1997","journal-title":"FASEB J"},{"key":"2022022810152016000_sct312394-bib-0093","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.bbamcr.2015.11.036","article-title":"3D culture for cardiac cells","volume":"1863","author":"Zuppinger","year":"2016","journal-title":"Biochim Biophys Acta, Mol Cell Res"},{"key":"2022022810152016000_sct312394-bib-0094","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/ten.tea.2009.0130","article-title":"Transplantation of a tissue-engineered human vascularized cardiac muscle","volume":"16","author":"Lesman","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"2022022810152016000_sct312394-bib-0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tibtech.2012.12.003","article-title":"Spheroid culture as a tool for creating 3D complex tissues","volume":"31","author":"Fennema","year":"2013","journal-title":"Trends Biotechnol"},{"key":"2022022810152016000_sct312394-bib-0096","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/adt.2014.573","article-title":"Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors","volume":"12","author":"Edmondson","year":"2014","journal-title":"Assay Drug Dev Technol"},{"key":"2022022810152016000_sct312394-bib-0097","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1073\/pnas.1615728114","article-title":"Modular assembly of thick multifunctional cardiac patches","volume":"114","author":"Fleischer","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022022810152016000_sct312394-bib-0098","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1016\/j.biomaterials.2014.04.091","article-title":"Microfluidic techniques for development of 3D vascularized tissue","volume":"35","author":"Hasan","year":"2014","journal-title":"Biomaterials"},{"key":"2022022810152016000_sct312394-bib-0099","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm1684","article-title":"Perfusion-decellularized matrix: using nature\u2019s platform to engineer a bioartificial heart","volume":"14","author":"Ott","year":"2008","journal-title":"Nat Med"},{"key":"2022022810152016000_sct312394-bib-0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/CIRCRESAHA.115.306874","article-title":"Bioengineering human myocardium on native extracellular matrixnovelty and significance","volume":"118","author":"Guyette","year":"2016","journal-title":"Circ Res"},{"key":"2022022810152016000_sct312394-bib-0101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.02.011","article-title":"Crossing kingdoms: using decellularized plants as perfusable tissue engineering scaffolds","volume":"125","author":"Gershlak","year":"2017","journal-title":"Biomaterials"},{"key":"2022022810152016000_sct312394-bib-0102","doi-asserted-by":"crossref","first-page":"E8372","DOI":"10.1073\/pnas.1707316114","article-title":"Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest","volume":"114","author":"Mills","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022022810152016000_sct312394-bib-0103","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nmat4782","article-title":"Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing","volume":"16","author":"Lind","year":"2017","journal-title":"Nat Mater"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fsctm.18-0052","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/8\/1\/66\/42630120\/stcltm_8_1_66.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/8\/1\/66\/42630120\/stcltm_8_1_66.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T10:21:00Z","timestamp":1646043660000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/8\/1\/66\/6403703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,9]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,10,9]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1002\/sctm.18-0052","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1,1]]},"published":{"date-parts":[[2018,10,9]]}}}